Visual acuity loss associated with excessive “dry macula” in exudative age-related macular degeneration

QR Code

Visual acuity loss associated with excessive “dry macula” in exudative age-related macular degeneration

Hidenori Takahashi,1–3 Yuji Inoue,1,2 Xue Tan,2,3 Satoru Inoda,1 Shinichi Sakamoto,1 Yusuke Arai,1 Yasuo Yanagi,4–6 Yujiro Fujino,2,3 Hidetoshi Kawashima1 1Department of Ophthalmology, Jichi Medical University, Shimotsuke, 2Department of Ophthalmology, The University of Tokyo, B...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Takahashi H, Inoue Y, Tan X, Inoda S, Sakamoto S, Arai Y, Yanagi Y, Fujino Y, Kawashima H
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2018
Sujets:	age-related macular degeneration intravitreal injections ranibizumab visual acuity dry macula Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/019e22ec701143f9846df5543fc28e21
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Intravitreal aflibercept for exudative age-related macular degeneration with good visual acuity: 2-year results of a prospective study
par: Sakamoto S, et autres
Publié: (2018)

Comment on: “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes”
par: Kaya A
Publié: (2016)

Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab
par: Nudleman E, et autres
Publié: (2016)

Randomised, Double-blind, Comparative Clinical Study of New Ranibizumab Biosimilar in Neovascular (Wet) Age-Related Macular Degeneration
par: Apsangikar P, et autres
Publié: (2021)

Visual outcome of intravitreal ranibizumab for exudative age-related macular degeneration: timing and prognosis
par: Canan H, et autres
Publié: (2014)

Twelve-month outcomes in patients with retinal vein occlusion treated with low-frequency intravitreal ranibizumab
par: Sakanishi Y, et autres
Publié: (2016)

Predictive Factors And Long-Term Visual Outcomes After Anti-Vascular Endothelial Growth Factor Treatment Of Retinal Angiomatous Proliferation
par: Maruyama-Inoue M, et autres
Publié: (2019)

Adding a Corticosteroid or Switching to Another Anti-VEGF in Insufficiently Responsive Wet Age-Related Macular Degeneration
par: Kaya C, et autres
Publié: (2019)

Evaluation of a paper-based visual acuity questionnaire
par: Uchino M, et autres
Publié: (2017)

Ranibizumab in monotherapy and combined with photodynamic therapy for retinal angiomatous proliferation
par: Arias L, et autres
Publié: (2016)

Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better
par: Khanani AM, et autres
Publié: (2019)

Early Ophthalmic Changes in Macula Does Not Correlate with Visual Function
par: Narayanan D, et autres
Publié: (2020)

Prefilled syringes for intravitreal drug delivery
par: Sassalos TM, et autres
Publié: (2019)

The effect of vitreomacular adhesion in exudative age-related macular degeneration on the results of ranibizumab intravitreal injection
par: Suzuki H, et autres
Publié: (2017)

Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials
par: Dugel PU, et autres
Publié: (2016)

Predictors of Visual Acuity After Treatment of Neovascular Age-Related Macular Degeneration – Current Perspectives
par: Phan LT, et autres
Publié: (2021)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
par: Fouda SM, et autres
Publié: (2017)

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
par: Karagiannis D, et autres
Publié: (2017)

Efficacy of Aflibercept versus Ranibizumab in the treatment of diabetic macular edema
par: Xiu-Xian Wang, et autres
Publié: (2021)

Treatment Course of Patients with Exudative Age-Related Macular Degeneration Using Ocular Hypotensives
par: Modjtahedi BS, et autres
Publié: (2020)

Trends in Real-World Neovascular AMD Treatment Outcomes in the UK
par: Mehta H, et autres
Publié: (2020)

Retinal Microvasculature Changes After Repair of Macula-off Retinal Detachment Assessed with Optical Coherence Tomography Angiography
par: McKay KM, et autres
Publié: (2020)

Visual acuity and patient satisfaction at varied distances and lighting conditions after implantation of an aspheric diffractive multifocal one-piece intraocular lens
par: Chang DH
Publié: (2016)

Microvascular and Structural Alterations of the Macula in Early to Moderate Glaucoma: An Optical Coherence Tomography-Angiography Study
par: Mael Lever, et autres
Publié: (2021)

Factors for Visual Acuity Improvement After Anti-VEGF Treatment of Wet Age-Related Macular Degeneration in China: 12 Months Follow up
par: Yan Lu, et autres
Publié: (2021)

Clinical Outcome and Drug Expenses of Intravitreal Therapy for Diabetic Macular Edema: A Retrospective Study in Sardinia, Italy
par: Chiara Altana, et autres
Publié: (2021)

Real-World Effectiveness, Treatment Pattern, and Safety of Ranibizumab in Korean Patients with Neovascular Age-Related Macular Degeneration: Subgroup Analyses from the LUMINOUS Study
par: Sagong M, et autres
Publié: (2021)

Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration
par: Koike N, et autres
Publié: (2019)

Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial
par: Gallemore RP, et autres
Publié: (2017)

Evaluation of contrast sensitivity and other visual function outcomes in diabetic macular edema patients following treatment switch to aflibercept from ranibizumab
par: Nixon DR, et autres
Publié: (2018)

Structural Changes in the Optic Disc and Macula Detected by Swept-Source Optical Coherence Tomography After Surgical Intraocular Pressure Reduction in Patients with Open-Angle Glaucoma
par: Vessani R, et autres
Publié: (2021)

Real-World Visual And Clinical Outcomes For Patients With Neovascular Age-Related Macular Degeneration Treated With Intravitreal Ranibizumab: An 8-Year Observational Cohort (AMD8)
par: Horner F, et autres
Publié: (2019)

Evaluation of the Safety of Bilateral Same-Day Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents: Experience of a Large Korean Retina Center
par: Jang K, et autres
Publié: (2020)

Multifocal ERG and Microperimetry Changes in Response to Ranibizumab Treatment of Neovascular AMD: Randomized Phase 2 Open-Label Study
par: Asahi MG, et autres
Publié: (2020)

Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes Group
par: Amoaku W, et autres
Publié: (2018)

Impact of Vitreal Tamponade on Functional Outcomes in Vitrectomy with ILM Peeling in Primary Macula-Involving Retinal Detachment: A Retrospective Analysis
par: Deiss M, et autres
Publié: (2020)

Real-World Outcomes in Patients with Diabetic Macular Edema Treated Long Term with Ranibizumab (VISION Study)
par: Van Aken E, et autres
Publié: (2020)

Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)
par: Blinder KJ, et autres
Publié: (2017)

Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2)
par: Jumper JM, et autres
Publié: (2018)

Location of submacular hemorrhage as a predictor of visual outcome after intravitreal ranibizumab for age-related macular degeneration
par: Karagiannis D, et autres
Publié: (2017)